High mortality rate in COVID-19 patients with myeloproliferative neoplasms after abrupt withdrawal of ruxolitinib
Author:
Barbui TizianoORCID, Vannucchi Alessandro Maria, Alvarez-Larran Alberto, Iurlo AlessandraORCID, Masciulli Arianna, Carobbio AlessandraORCID, Ghirardi Arianna, Ferrari Alberto, Rossi Giuseppe, Elli Elena, Andrade-Campos Marcio Miguel, Kabat Mercedes Gasior, Kiladjian Jean-Jaques, Palandri FrancescaORCID, Benevolo Giulia, Garcia-Gutierrez Valentin, Fox Maria Laura, Foncillas Maria AngelesORCID, Morcillo Carmen Montoya, Rumi ElisaORCID, Osorio Santiago, Papadopoulos PetrosORCID, Bonifacio MassimilianoORCID, Cervantes Keina Susana Quiroz, Serrano Miguel Sagues, Carreno-Tarragona GonzaloORCID, Sobas Marta Anna, Lunghi Francesca, Patriarca Andrea, Elorza Begona Navas, Angona Anna, Mazo Elena Magro, Koschmieder SteffenORCID, Ruggeri Marco, Cuevas Beatriz, Hernandez-Boluda Juan CarlosORCID, Abadia Emma Lopez, Cirici Blanca Xicoy, Guglielmelli PaolaORCID, Garrote Marta, Cattaneo Daniele, Daffini Rosa, Cavalca Fabrizio, Bellosillo Beatriz, Benajiba Lina, Curto-Garcia Natalia, Bellini Marta, Betti Silvia, De Stefano ValerioORCID, Harrison Claire, Rambaldi AlessandroORCID
Publisher
Springer Science and Business Media LLC
Subject
Oncology,Cancer Research,Hematology
Reference17 articles.
1. Richardson S, Hirsch JS, Narasimhan M, Crawford JM, McGinn T, Davidson KW, et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City Area. JAMA. 2020;323:2052–9. 2. Xu J, Wang L, Zhao L, Li F, Liu J, Zhang L, et al. Risk assessment of venous thromboembolism and bleeding in COVID-19 patients. Research Square 2020. On line publication. https://doi.org/10.21203/rs.3.rs-18340/v1. 3. Carsana L, Sonzogni A, Nasr A, Rossi RS, Pellegrinelli A, Zerbi P, et al. Pulmonary post-mortem findings in a series of COVID-19 cases from northern Italy: a two-centre descriptive study. Lancet Infect Dis. 2020;20:1135–40. 4. Breccia M, Piciocchi A, De Stefano V, Finazzi G, Iurlo A, Fazi P, et al. COVID-19 in Philadelphia-negative myeloproliferative disorders: a GIMEMA survey. Leukemia. 2020;34:2813–4. 5. Palandri F, Piciocchi A, De Stefano V, Breccia M, Finazzi G, Iurlo A, et al. How the coronavirus pandemic has affected the clinical management of Philadelphia-negative chronic myeloproliferative neoplasms in Italy-a GIMEMA MPN WP survey. Leukemia. 2020;34:2805–8.
Cited by
72 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
|
|